Faraz Ali - 29 Jul 2021 Form 3 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Executive Officer, Director
Signature
/s/Leone Patterson Attorney-in-Fact for Faraz Ali
Issuer symbol
TNYA
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 17:22:08 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNYA Stock Option (Right to buy) 29 Jul 2021 Common Stock 425,000 $0.6600 Direct F1
holding TNYA Stock Option (Right to buy) 29 Jul 2021 Common Stock 41,666 $2.70 Direct F2
holding TNYA Stock Option (Right to buy) 29 Jul 2021 Common Stock 416,666 $5.64 Direct F3
holding TNYA Stock Option (Right to buy) 29 Jul 2021 Common Stock 166,666 $9.36 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/5th of the shares subject to the option granted on September 6, 2018 became vested and exercisable as of June 27, 2019 and 1/60th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F2 1/48th of the shares subject to the option granted on March 10, 2020 became vested and exercisable as of April 10, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F3 1/48th of the shares subject to the option granted on February 27, 2021 became vested and exercisable as of March 27, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F4 1/48th of the shares subject to the option granted on June 17, 2021 became vested and exercisable as of July 17, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.

Remarks:

Date set forth above represents the effective date of the Issuer's initial public offering.